Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16329)	10/8/2003 10:57:30 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

If Xoma loves BPI so much, why is this new probe not sponsored by Xoma? The investigator is sponsoring the trial. I have asked several times if this type of probe can result in "orphan drug designation". I think it can but no one else has confirmed that it can or stated that it can't. Yes I am pleased that the probe has started and that it is only the first in the series. But would like to know why Xoma is leaving it to others to sponsor these studies if they have such great confidence in Neuprex/BPI.